Key points
- Health Minister Dr. Karnal Dhani Ram Shandil warned that pharma companies with repeated drug sample failures may be closed or barred from the state.
- Since March 2025, 1,471 drug samples from Himachal Pradesh have failed quality tests.
- The state government will discuss strengthening drug quality laws in an upcoming cabinet meeting.
Health Minister Dr. Karnal Dhani Ram Shandil stated that pharmaceutical industries whose drug samples repeatedly fail quality tests will face strict action. This includes the possibility of closure and being barred from operating within Himachal Pradesh.
The minister said that people who compromise on health and life for profit will not be spared. He described the repeated failure of drug samples as a blow to humanity.
The state government will discuss the issue in an upcoming cabinet meeting and intends to strengthen laws to ensure drug quality.
Drug samples from the state have failed in multiple instances, including medications for fever, heart conditions, and children's syrup.

Since March 2025, 1,471 drug samples from Himachal Pradesh have failed. In 2026, 93 samples failed, with nearly 62 of those failures occurring in August 2026. Additionally, 82 samples failed during 20252026.
The State Drug Controller has conducted independent investigations and issued notices in response to these failures. The Drug and Cosmetics Act provides for action against companies when samples fail.
Dr. Karnal Dhani Ram Shandil emphasised that the Drug Control Department must monitor quality and take effective action rather than just collecting samples.
The minister stated that investigations should determine if failures are caused by the production process, quality control, storage, or other technical reasons. He added that any suspicion of negligence or collusion in the quality control system must be investigated impartially.